Gilead Sciences (GILD) News Today $118.64 +1.90 (+1.62%) As of 10:00 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Gilead Sciences Up Today?Toggle Visibility of Why Is Gilead Sciences Up Today?Gilead Sciences, Inc. (NASDAQ: GILD) – Key Drivers Behind Today’s Stock Movement Positive Sentiment: Cantor Fitzgerald lifts its FY2025 EPS forecast for GILD to $8.18 (up from $8.15) and maintains an “Overweight” rating with a $135 price target. Positive Sentiment: Cantor Fitzgerald raises its price target on GILD from $129 to $135, implying roughly 15% upside from current levels. MarketScreener Positive Sentiment: Citigroup reaffirms its Buy recommendation on GILD, supporting near-term investor confidence. MSN Positive Sentiment: Weiss Ratings reconfirms a Buy (B) rating on GILD shares. MarketBeat Neutral Sentiment: Gilead will release its Q3 2025 financial results and guidance on October 30 after market close, with a live webcast to follow. Business Wire Neutral Sentiment: Short interest remains immaterial, with zero shares reported as of October 9 and a 0.0 days-to-cover ratio based on average trading volume. Negative Sentiment: Cantor Fitzgerald cuts its FY2026 EPS forecast for GILD from $9.05 to $8.75, although it keeps an “Overweight” rating and a $135 target. Negative Sentiment: Gilead trims its 2020 sales outlook for remdesivir after performance fell short of expectations. Reuters Posted 26m agoAI Generated. May Contain Errors. GILD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period TFR Capital LLC. Makes New $283,000 Investment in Gilead Sciences, Inc. $GILD3 hours ago | marketbeat.comGilead shares rise after United States approves remdesivir as COVID-19 drug4 hours ago | reuters.comGilead cuts 2020 sales outlook as COVID-19 drug remdesivir falls short4 hours ago | reuters.comTectonic Advisors LLC Increases Stake in Gilead Sciences, Inc. $GILD5 hours ago | marketbeat.comTrifecta Capital Advisors LLC Has $339,000 Stock Position in Gilead Sciences, Inc. $GILD5 hours ago | marketbeat.comCallan Family Office LLC Purchases 63,300 Shares of Gilead Sciences, Inc. $GILD5 hours ago | marketbeat.comBlair William & Co. IL Decreases Stock Holdings in Gilead Sciences, Inc. $GILD5 hours ago | marketbeat.comUS Bancorp DE Sells 22,670 Shares of Gilead Sciences, Inc. $GILD5 hours ago | marketbeat.comVontobel Holding Ltd. Lowers Holdings in Gilead Sciences, Inc. $GILDOctober 10 at 4:51 AM | marketbeat.comMaryland State Retirement & Pension System Increases Position in Gilead Sciences, Inc. $GILDOctober 10 at 4:43 AM | marketbeat.comGilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025October 9 at 4:05 PM | businesswire.comCitigroup Maintains Gilead Sciences (GILD) Buy RecommendationOctober 9 at 5:36 AM | msn.comFluent Financial LLC Raises Stake in Gilead Sciences, Inc. $GILDOctober 9 at 4:57 AM | marketbeat.comKingswood Wealth Advisors LLC Reduces Stock Position in Gilead Sciences, Inc. $GILDOctober 9 at 4:11 AM | marketbeat.comGilead Sciences (NASDAQ:GILD) Given "Buy (B)" Rating at Weiss RatingsOctober 9 at 3:16 AM | marketbeat.comGilead Sciences Sees Relative Strength Rating Rise To 72October 8 at 12:36 AM | msn.comBreaking Down Gilead Sciences: 6 Analysts Share Their ViewsOctober 8 at 12:36 AM | benzinga.comRoyal Bank Of Canada Increases Gilead Sciences (NASDAQ:GILD) Price Target to $100.00October 8 at 9:29 AM | marketbeat.comGilead Sciences (NASDAQ:GILD) Price Target Raised to $135.00 at CitigroupOctober 8 at 9:29 AM | marketbeat.com4 Bank of America Strong Buy Growth 10 Stocks That All Pay DividendsOctober 8 at 7:17 AM | 247wallst.comWESPAC Advisors LLC Purchases 7,248 Shares of Gilead Sciences, Inc. $GILDOctober 8 at 6:47 AM | marketbeat.comTriasima Portfolio Management inc. Increases Holdings in Gilead Sciences, Inc. $GILDOctober 8 at 5:48 AM | marketbeat.comFriedenthal Financial Purchases Shares of 9,152 Gilead Sciences, Inc. $GILDOctober 8 at 5:20 AM | marketbeat.comPrime Capital Investment Advisors LLC Decreases Holdings in Gilead Sciences, Inc. $GILDOctober 8 at 4:33 AM | marketbeat.comValeo Financial Advisors LLC Boosts Stake in Gilead Sciences, Inc. $GILDOctober 8 at 4:25 AM | marketbeat.comDAVENPORT & Co LLC Sells 16,332 Shares of Gilead Sciences, Inc. $GILDOctober 8 at 4:16 AM | marketbeat.comShell Asset Management Co. Buys 22,026 Shares of Gilead Sciences, Inc. $GILDOctober 7 at 7:33 AM | marketbeat.comGilead Sciences: Strategic Positioning and Extended Patent Protection Justify Buy RatingOctober 7 at 7:30 AM | tipranks.comKLP Kapitalforvaltning AS Purchases 20,100 Shares of Gilead Sciences, Inc. $GILDOctober 7 at 6:29 AM | marketbeat.comSteelPeak Wealth LLC Lowers Position in Gilead Sciences, Inc. $GILDOctober 7 at 5:33 AM | marketbeat.comGilead Sciences, Inc. $GILD Shares Bought by Merit Financial Group LLCOctober 7 at 4:34 AM | marketbeat.comSimplicity Wealth LLC Boosts Stock Holdings in Gilead Sciences, Inc. $GILDOctober 7 at 4:22 AM | marketbeat.comGilead Shares Rise After Reaching Settlement on Biktarvy Patent DisputesOctober 7 at 3:41 AM | msn.comGilead Reaches Settlement To Block Biktarvy Generics Until 2036October 6, 2025 | benzinga.comGilead stock rises after settling Biktarvy patent disputesOctober 6, 2025 | za.investing.comGilead Sciences settles patent litigations related to BiktarvyOctober 6, 2025 | seekingalpha.comGilead Sciences Settles Patent Litigation on BiktarvyOctober 6, 2025 | tipranks.comGrimes & Company Inc. Has $17.44 Million Stock Position in Gilead Sciences, Inc. $GILDOctober 6, 2025 | marketbeat.comBridgePort Financial Solutions LLC Raises Stock Position in Gilead Sciences, Inc. $GILDOctober 5, 2025 | marketbeat.comBoston Common Asset Management LLC Lowers Stock Position in Gilead Sciences, Inc. $GILDOctober 5, 2025 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Gilead Sciences (GILD)October 4, 2025 | theglobeandmail.comAMF Tjanstepension AB Purchases 154,530 Shares of Gilead Sciences, Inc. $GILDOctober 4, 2025 | marketbeat.comGilead Sciences, Inc. $GILD Holdings Boosted by LGT Fund Management Co Ltd.October 4, 2025 | marketbeat.com111 Capital Sells 9,679 Shares of Gilead Sciences, Inc. $GILDOctober 4, 2025 | marketbeat.comQRG Capital Management Inc. Raises Stock Holdings in Gilead Sciences, Inc. $GILDOctober 4, 2025 | marketbeat.comStock Yards Bank & Trust Co. Grows Holdings in Gilead Sciences, Inc. $GILDOctober 4, 2025 | marketbeat.comAscent Group LLC Grows Position in Gilead Sciences, Inc. $GILDOctober 4, 2025 | marketbeat.comGilead Sciences, Inc. $GILD Stock Position Cut by Polaris Capital Management LLCOctober 4, 2025 | marketbeat.comLecap Asset Management Ltd. Sells 6,323 Shares of Gilead Sciences, Inc. $GILDOctober 4, 2025 | marketbeat.comGilead Foundation Commits Over $6.5M in New Grant Funding to Support STEM Education PathwaysOctober 3, 2025 | finance.yahoo.com Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼1.270.77▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼5555▲GILD Articles Average Week Get the Latest News and Ratings for GILD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Gilead Sciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AMGN News Today LGND News Today MRNA News Today REGN News Today VIR News Today VRTX News Today ABBV News Today MRK News Today PFE News Today ALNY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredWhy This Titanium Explorer Caught Rio Tinto’s EyeAs U.S. defense spending crosses $1 trillion, drones, hypersonics, and next-gen aerospace are taking center st...Capital Trends | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHave you heard of the Texas Royalty Plan?There is a backdoor way you could collect a check, four times a year, thanks to the exploding oil industry in ...Brownstone Research | SponsoredTesla’s $30 trillion pivotElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
